PharmaCyte Biotech (PMCB) Receivables - Net (2024 - 2025)
PharmaCyte Biotech (PMCB) has disclosed Receivables - Net for 5 consecutive years, with $3.4 million as the latest value for Q1 2025.
- On a quarterly basis, Receivables - Net changed N/A to $3.4 million in Q1 2025 year-over-year; TTM through Jan 2025 was $3.4 million, a N/A change, with the full-year FY2024 number at $2.8 million, changed N/A from a year prior.
- Receivables - Net was $3.4 million for Q1 2025 at PharmaCyte Biotech, up from $2.8 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $3.4 million in Q1 2025 to a low of $2.8 million in Q2 2024.